Insider Trading History of Warden Charles M

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Warden Charles M since 2007. The trader's CIK number is 1354802. At the time of the last reporting, Warden Charles M was the 10% Owner of Ocular Therapeutix, Inc. (stock ticker symbol OCUL). Also see all insider trading activities at Ocular Therapeutix, Inc.

Note that in the past Warden Charles M also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Helicos Biosciences Corp (HLCS) by Warden Charles M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2009 HLCS 242,931 $625,061 0 $0 0 $0
2008 HLCS 8,620,690 $0 0 $0 0 $0
2007 HLCS 111,111 $999,999 0 $0 0 $0

Yearly summary of insider trading at Ocular Therapeutix, Inc (OCUL) by Warden Charles M

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2015 OCUL 0 $0 747,000 $16,434,000 0 $0


Insider trading activities at 2 companies by Warden Charles M:

1. Helicos Biosciences Corp (HLCS)

2. Ocular Therapeutix, Inc (OCUL)

Table 1. Insider trading of Helicos Biosciences Corp (HLCS) by Warden Charles M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2009-09-18 HLCS Buy 242,931 2.57 625,061
2008-12-23 HLCS Buy 8,620,690 .00 0
2007-05-30 HLCS Buy 111,111 9.00 999,999

Table 2. Insider trading of Ocular Therapeutix, Inc (OCUL) by Warden Charles M

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2015-06-15 OCUL Sale 320,000 22.00 7,040,000
2015-06-10 OCUL Sale 427,000 22.00 9,394,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Warden Charles M (10% Owner of Ocular Therapeutix, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.